|
PWWP2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.023610E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.584810E-01 |
| Normal-vs-Stage2 |
1.738620E-01 |
| Normal-vs-Stage3 |
6.251800E-02 |
| Normal-vs-Stage4 |
1.683030E-01 |
| Stage1-vs-Stage2 |
7.183800E-01 |
| Stage1-vs-Stage3 |
4.314600E-01 |
| Stage1-vs-Stage4 |
9.011000E-01 |
| Stage2-vs-Stage3 |
8.494200E-01 |
| Stage2-vs-Stage4 |
8.412400E-01 |
| Stage3-vs-Stage4 |
6.539800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.049000E-01 |
| Normal-vs-AfricanAmerican |
9.464000E-01 |
| Normal-vs-Asian |
4.187000E-01 |
| Caucasian-vs-AfricanAmerican |
2.867000E-01 |
| Caucasian-vs-Asian |
5.811600E-01 |
| AfricanAmerican-vs-Asian |
5.800800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.642810E-01 |
| Normal-vs-Female |
9.979900E-02 |
| Male-vs-Female |
8.186400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.758200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.679900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.171620E-01 |
| Normal-vs-Age(81-100Yrs) |
3.063800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.464600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.844400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.975000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.822800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.929400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.098200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.443760E-01 |
| Classical-VS-Follicular |
1.205910E-04 |
| Classical-VS-Other |
2.988400E-01 |
| Classical-VS-Normal |
6.420800E-01 |
| Tall-VS-Follicular |
3.478200E-01 |
| Tall-VS-Other |
7.827600E-01 |
| Tall-VS-Normal |
1.057960E-01 |
| Follicular-VS-Other |
8.102200E-01 |
| Follicular-VS-Normal |
2.862200E-03 |
| Other-VS-Normal |
2.277400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.222400E-02 |
| Normal-vs-N1 |
3.206400E-01 |
| N0-vs-N1 |
3.083800E-01 |
|
|
